COPD Research

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
Martin R. Stämpfli, PhD, professor in the department of medicine at McMaster University, explains the development of COPD in his lecture at the seminar “COPD—Bridging the Gap between Science and Clinical Care.”

Related Articles
As a result of confusing sensations of breathlessness with asthma symptoms, overweight and obese children tend to report poorer asthma control and overuse rescue medications.
Children infected with enterovirus have a 48% increased risk of developing type 1 diabetes.
Even though smoking can exacerbate respiratory conditions and limit the efficacy of their treatment, patients often purchase cigarettes while filling prescriptions for asthma or antihypertensive drugs at pharmacies.
Notable outbreaks over the past 2 decades have qualified enterovirus D68 as an emerging pathogen.
Latest Issues
$auto_registration$